Illustration of extracellular vesicles and the skin barrier, concept only and not to scale

Exosomes in Skincare: The Science Behind the Latest Anti-Aging Innovation

Can tiny biological messengers really rejuvenate your skin? Let's examine the clinical evidence.

Exosomes are having quite a moment in skincare. From Korean beauty serums to high-end dermatology clinics, these microscopic particles are being promoted for everything from collagen stimulation to wrinkle reduction and skin repair.

The promises sound almost too good to be true.

But unlike many trendy skincare ingredients, exosomes are rooted in a genuinely fascinating area of biomedical research: cell-to-cell communication and tissue regeneration.

So, is there enough clinical evidence to justify the excitement?

A series of clinical studies and systematic reviews published between 2023 and 2026 provides some intriguing answers.

What Are Exosomes and How Do They Work?

Our skin is much more than a collection of cells sitting next to each other. Keratinocytes, fibroblasts, immune cells, and other cell populations continuously exchange biochemical signals to regulate inflammation, tissue repair, and extracellular matrix production.

One mechanism involves extracellular vesicles (EVs)—microscopic particles surrounded by a lipid membrane that can transport proteins, lipids, and nucleic acids between cells.

Exosomes are a specific subtype of extracellular vesicles originating from the endosomal system within cells.

Their biological cargo may influence how recipient cells behave.

For example, researchers are investigating whether extracellular vesicles can influence:

  • Fibroblast activity: Fibroblasts produce collagen and other structural components that contribute to skin firmness and elasticity.
  • Extracellular matrix remodeling: Signals may affect collagen synthesis and enzymes involved in its degradation.
  • Inflammatory pathways: Certain vesicle preparations can modulate inflammatory signaling under experimental conditions.
  • Epidermal barrier function: Laboratory studies have observed changes in molecules involved in hydration and barrier maintenance.

However, an important scientific clarification is needed.

The International Society for Extracellular Vesicles recommends using the broader term extracellular vesicles unless the specific cellular origin of the particles has been established.

In other words, not every ingredient marketed as an exosome has necessarily been proven to contain genuine exosomes.

This is not merely scientific perfectionism. Different particle sources and manufacturing methods can produce biologically different preparations.

Can Exosomes Stimulate Collagen Production?

This is where the science becomes particularly interesting.

Skin aging is associated with multiple biological changes, including reduced collagen production, changes in elastic fibers, and increased activity of enzymes involved in extracellular matrix degradation.

Preclinical studies suggest that some extracellular vesicle preparations may influence these processes.

One example comes from a 2024 study by Lu and colleagues investigating bovine milk-derived extracellular vesicles.

In laboratory experiments involving human keratinocytes and fibroblasts, the researchers observed changes in molecules associated with skin hydration and extracellular matrix regulation, including:

Filaggrin (FLG): A structural protein important for epidermal barrier function. Its breakdown products contribute to natural moisturizing factors.

Aquaporin-3 (AQP3): A membrane channel involved in the transport of water and glycerol, both relevant to epidermal hydration.

Hyaluronan synthase 2 (HAS2): An enzyme involved in hyaluronic acid synthesis.

Collagen types I and III: Structural proteins contributing to the mechanical properties of the dermis.

The investigators also observed favorable effects on collagen-related expression in UV-exposed fibroblast experiments.

These findings provide a plausible biological rationale for investigating extracellular vesicles in skin aging.

But there is a major distinction:

A change in collagen-related gene expression in laboratory-grown cells is not equivalent to a clinically demonstrated reduction in facial wrinkles.

A change in collagen-related gene expression in laboratory-grown cells is not equivalent to a clinically demonstrated reduction in facial wrinkles.

To establish that, we need human clinical studies.

What Do Human Clinical Studies Actually Show?

Clinical research at a glance

Three studies, three very different treatment settings. Comparing their designs is just as important as comparing the numbers.

Study Participants & method Key result Important limitation
Park et al. (2023) 28 people; microneedling + exosome preparation vs microneedling + saline Wrinkle roughness: −13.4% vs −7.1% Small study; results involve microneedling
Yen et al. (2026) 60 people; radiofrequency microneedling ± extracellular vesicles Wrinkle-score improvement: 12.59 vs 9.28 points Unblinded; 12-week follow-up
Lu et al. (2024) 31 women; topical milk-derived vesicles, twice daily Measured wrinkle area: −9.59% after 28 days No separate placebo-control group

These figures come from different study designs and outcome measurements and should not be compared as head-to-head product efficacy.

Study 1: Exosomes Combined With Microneedling — A Randomized Trial (2023)

One particularly interesting trial was published by Park and colleagues in the Journal of Cosmetic Dermatology.

Study design

Twenty-eight participants with signs of facial skin aging underwent three treatment sessions over a 12-week study period.

The investigators used a randomized split-face design:

  • One side received microneedling followed by a human adipose-derived stem-cell exosome-containing solution.
  • The opposite side received microneedling followed by saline.

This design is valuable because each participant serves as their own control.

Clinical findings

At the final assessment, the exosome-treated side showed greater improvement in several objective measurements.

Park et al., 2023 — Results after microneedling

Outcome Exosome + microneedling Microneedling control
Wrinkle roughness parameter Rz −13.4% −7.1%
Skin elasticity +11.3% −3.3%
Hydration +6.5% +4.5%
Melanin index −9.9% −1.0%

Percentage changes are reported measurements; this does not represent the effect of applying a serum to untreated skin.

The between-treatment differences were statistically significant for these reported measurements.

For example, the difference in the wrinkle roughness parameter Rz reached p = 0.007.

Histological examination also suggested greater collagen and elastic-fiber deposition on the exosome-treated side.

What does this mean clinically?

The study provides preliminary evidence that adding this exosome-containing preparation to microneedling may improve short-term skin-aging outcomes compared with microneedling alone.

However, the study involved only 28 participants, and the final follow-up occurred six weeks after the last treatment.

Most importantly, the preparation was applied in conjunction with microneedling.

We cannot assume that an ordinary exosome serum applied to intact skin would produce the same results.

Study 2: A Larger Split-Face Trial Published in August 2026

A more recent study by Yen and colleagues investigated extracellular vesicles following radiofrequency microneedling.

Study design

Sixty adults underwent split-face treatment. One side received radiofrequency microneedling followed by topical extracellular vesicles, while the other side received radiofrequency microneedling alone.

Assessments were performed at baseline, four weeks, and twelve weeks.

Results

60 participants · Week 12 outcomes

At week 12, the investigators reported:

  • A mean wrinkle-severity score improvement of 12.59 points on the EV-treated side.
  • A corresponding improvement of 9.28 points on the control side.
  • A paired mean difference of 3.32 points, with a 95% confidence interval of 2.55–4.08.

The difference favors the EV combination after radiofrequency microneedling, not an at-home cosmetic serum.

Additional measurements, including texture, hydration, erythema, and pigmentation, generally favored the combination treatment.

How strong is this evidence?

The findings are encouraging because both facial sides received the same underlying procedure.

However, the trial was unblinded, lasted only 12 weeks, and did not include histological or molecular confirmation of the proposed mechanisms.

It is a positive clinical signal—not definitive evidence of long-term collagen regeneration.

Study 3: Can Exosomes Work Without Microneedling?

This question is especially relevant to skincare consumers.

In 2024, Lu and colleagues evaluated topical bovine milk-derived extracellular vesicles in 31 female volunteers aged 26–45 years.

The participants applied the preparation twice daily for 28 days.

31 participants · 28-day topical study

Reported changes included:

  • 5.6% increase in skin moisture measurements.
  • 7.24% improvement in the R2 elasticity parameter.
  • 9.59% reduction in measured wrinkle area.
  • 4.99% reduction in wrinkle count.

Interpretation: Without a separate placebo-treated control group, these changes cannot establish a causal treatment effect.

These are intriguing results, particularly because they were obtained without microneedling.

However, the human portion of the study had no separate placebo-treated control group.

This matters because changes in hydration, measurement conditions, and other factors can influence apparent wrinkle improvement.

The study also received funding from an exosome technology company.

Industry funding does not automatically invalidate scientific research, but independent replication with blinded, vehicle-controlled trials would substantially strengthen these findings.

Clinical interpretation: Topical application without a procedure is worth investigating, but this study cannot establish that the observed improvements were specifically caused by extracellular vesicles.

What Do the 2026 Systematic Reviews Conclude?

Individual studies are informative, but systematic reviews help us evaluate the broader body of evidence.

A 2026 systematic review by Gaebe and colleagues included 16 studies with a total of 503 participants receiving extracellular vesicle-based interventions for nonsurgical facial rejuvenation.

Most studies reported improvement in at least one outcome, such as wrinkles, skin hydration, elasticity, or pigmentation.

However, the authors identified important methodological concerns:

  • Many studies had moderate to critical risk of bias.
  • Treatment formulations and delivery methods varied.
  • Outcome assessments were inconsistent.
  • Long-term follow-up was generally insufficient.

Using the GRADE framework, the reviewers assessed the certainty of evidence as low or very low.

Another 2026 scoping review by Knauer and colleagues identified 18 studies investigating topical exosome preparations.

Ten combined topical application with additional delivery methods, while only eight evaluated topical application alone.

This distinction is central when translating clinical research into advice for people buying skincare products.

A separate 2026 meta-analysis by Stack and colleagues included 39 studies across skin and hair indications and reported an average facial-wrinkle reduction of 20.2% in the analyzed data.

That figure sounds impressive, but it should not be interpreted as proof that purchasing an exosome serum will reduce wrinkles by 20%.

Differences in treatment protocols, assessment methods, and study quality limit how confidently these results can be generalized.

These reviews also include overlapping primary studies, so their participant numbers should not be added together as though they represent entirely independent evidence.

How strong is the overall evidence?

2026 review Scope What readers should take away
Gaebe et al. 16 studies, 503 participants Overall certainty: low or very low
Knauer et al. 18 studies 10 involved extra delivery methods; 8 topical-only
Stack et al. 39 studies across skin and hair Pooled outcomes are not a prediction for a retail serum

These reviews include some overlapping primary studies and must not be counted as independent trial populations.

Why Does the Skin Barrier Matter So Much?

Even when an ingredient demonstrates biological activity in laboratory experiments, it still needs to reach an appropriate target in living skin.

The stratum corneum—the outermost epidermal layer—is remarkably effective at limiting the penetration of many substances.

Extracellular vesicles contain a membrane and complex molecular cargo, making delivery and stability particularly important formulation challenges.

Researchers are investigating whether different vesicle preparations can penetrate or interact with intact skin, as well as whether microneedling and other procedures enhance their delivery.

However, the penetration behavior of one experimentally characterized preparation cannot automatically be generalized to every commercial exosome serum.

A scientifically interesting ingredient is not necessarily a clinically effective finished product.

That is why product-specific formulation studies are so important.

A scientifically interesting ingredient is not necessarily a clinically effective finished product.

Are Exosome Skincare Products Safe?

Small human studies of certain topical preparations have generally reported acceptable short-term tolerability, with no serious treatment-related events reported in the 2026 systematic review.

However, short follow-up and relatively small study populations limit the ability to detect uncommon or delayed adverse effects.

Safety also depends on the preparation's origin, purification, sterility, manufacturing quality, and route of administration.

Topical cosmetic application and injection are very different interventions.

The US Food and Drug Administration has warned about unapproved exosome-based medical interventions, including reports of serious adverse events associated with certain injected products.

These warnings should not be interpreted as evidence that all topical exosome cosmetics present the same risk, but neither should a reassuring safety result from one preparation be generalized to the entire category.

An additional difficulty is the lack of standardization in commercial products.

Researchers have highlighted limited publicly available information about the biological origin, processing, and stability of some cosmetics marketed as containing exosomes.

Exosomes vs Retinoids: Which Has Stronger Clinical Evidence?

If your goal is reducing wrinkles caused by photoaging, established retinoid treatments currently have a much stronger clinical evidence base.

A 2025 systematic review and meta-analysis of topical tretinoin identified eight randomized controlled trials involving 1,361 participants.

Compared with vehicle treatments, tretinoin significantly improved both fine and coarse wrinkles associated with photodamage.

There are important distinctions between prescription tretinoin and cosmetic retinol or retinal formulations, but retinoids as a class have been investigated much more extensively than topical exosome cosmetics.

Exosomes may eventually offer additional possibilities for skin rejuvenation.

For now, however, they should not be presented as clinically superior to well-established retinoid treatments.

And of course, no anti-aging routine should overlook photoprotection.

Consistent use of an appropriate sunscreen remains a fundamental part of preventing ultraviolet-induced skin damage.

For readers interested in established skincare options, explore the sun protection selection at More About Skin or learn more about COSRX The Retinol 0.3 Cream.

Retinoids require gradual introduction, can cause irritation, and should be avoided during pregnancy.

Should You Buy an Exosome Serum?

Exosome cosmetics may become an interesting addition to evidence-based skincare, but choosing one requires more than reading the marketing promises.

Before purchasing, consider whether the manufacturer identifies the vesicle source and provides information about characterization, stability, and human clinical testing of the actual finished product.

Pay particular attention to whether the claimed benefits were demonstrated with ordinary topical use or after professional procedures.

A product supported only by laboratory evidence should not be advertised as though its clinical effects have already been established.

The most important question is not simply does this serum contain exosomes?

It is has this particular formulation demonstrated a meaningful benefit in well-controlled human trials?

Frequently Asked Questions

COMMON QUESTIONS · EVIDENCE-BASED ANSWERS

Do exosome serums really reduce wrinkles?

Early human studies have reported measurable improvements in wrinkle-related outcomes. However, many treatments were combined with microneedling or other procedures, and well-controlled evidence for ordinary at-home serums remains limited.

Are plant-derived exosomes the same as human-derived exosomes?

No. Extracellular vesicle preparations can differ substantially in their biological composition and potential activity depending on their source. Clinical results from one source cannot automatically be applied to another.

How long does it take to see results?

Some published trials have evaluated changes after four to twelve weeks. However, there is insufficient evidence to establish a reliable timeline for exosome cosmetics generally.

Can I apply an exosome serum after microneedling at home?

Products applied to disrupted skin require particular attention to sterility, formulation suitability, and infection risk. Clinical results involving controlled professional procedures should not be interpreted as support for using ordinary cosmetic serums after home microneedling.

The Dermatologist's Verdict

Exosomes represent a genuinely exciting area of regenerative dermatology.

Their biological functions provide a plausible scientific basis for investigating tissue repair, inflammation, and skin aging. Early randomized studies also suggest that certain extracellular vesicle preparations may offer additional benefits when combined with microneedling.

However, the overall clinical evidence remains heterogeneous, and the certainty of evidence is limited.

We still need larger, independently conducted, blinded studies using standardized preparations, appropriate control groups, and longer follow-up periods.

Exosomes are scientifically promising, but their role in routine anti-aging skincare has not yet been established.

And perhaps that is the most useful distinction in modern skincare: an ingredient can be fascinating without being ready to replace the treatments we already know work.

Your skin deserves innovation—but it also deserves evidence.


Scientific References

  1. Knauer G, et al. Clinical Evidence and Commercial Landscape of Topical Exosomes for Skin Rejuvenation: A Scoping Review. Aesthetic Surgery Journal. 2026. PMID: 42411735. DOI: 10.1093/asj/sjag141.
  2. Gaebe K, et al. Effectiveness and Safety of Extracellular Vesicle-Based Therapies for Nonsurgical Facial Rejuvenation: A Systematic Review. Facial Plastic Surgery & Aesthetic Medicine. 2026. PMID: 42487416. DOI: 10.1177/26893614261457879.
  3. Park GH, et al. Efficacy of combined treatment with human adipose tissue stem cell-derived exosome-containing solution and microneedling for facial skin aging: A 12-week prospective, randomized, split-face study. Journal of Cosmetic Dermatology. 2023;22:3418–3426. PMID: 37377400. DOI: 10.1111/jocd.15872.
  4. Yen CW, Huang HW, Lin CJ. Radiofrequency Microneedling Combined With Topical Extracellular Vesicle Preparation for Facial Rejuvenation: A Randomized Split-Face Controlled Study. Journal of Craniofacial Surgery. 2026. PMID: 42635327. DOI: 10.1097/SCS.0000000000013266.
  5. Lu L, et al. Novel roles of bovine milk-derived exosomes in skin antiaging. Journal of Cosmetic Dermatology. 2024. PMID: 38105431. DOI: 10.1111/jocd.16112.
  6. Stack ER, et al. Clinical Advances in Exosome-Based Therapies for Aesthetic Medicine: A Systematic Review and Meta-analysis of Human Clinical Trials. Aesthetic Surgery Journal. 2026. PMID: 41800726. DOI: 10.1093/asj/sjaf178.
  7. Welsh JA, et al. Minimal information for studies of extracellular vesicles (MISEV2023): From basic to advanced approaches. Journal of Extracellular Vesicles. 2024. Full article.
  8. Tretinoin for Photodamaged Facial Skin: Systematic Review and Meta-Analysis of Randomized Controlled Trials. 2025. PMID: 41236273.

Relevant skincare options at More About Skin

For readers exploring the science, here are two products currently stocked by More About Skin. These are different choices: one uses a more established retinoid ingredient class; the other is an exosome-labelled cosmetic product that should not be confused with the preparations tested in clinical procedures.

Retinoids may irritate skin and should be avoided during pregnancy. Exosome clinical outcomes discussed above cannot be attributed to the APLB product without product-specific human trials.

Back to blog

Leave a comment